Pictet Asset Management Holding Sa Biocryst Pharmaceuticals Inc Transaction History
Pictet Asset Management Holding Sa
- $93.5 Billion
- Q2 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 969,041 shares of BCRX stock, worth $6.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
969,041
Previous 612,324
58.26%
Holding current value
$6.6 Million
Previous $4.59 Million
89.07%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding BCRX
# of Institutions
315Shares Held
201MCall Options Held
930KPut Options Held
553K-
Vanguard Group Inc Valley Forge, PA20.5MShares$140 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$136 Million0.0% of portfolio
-
State Street Corp Boston, MA8.51MShares$57.9 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.46MShares$57.6 Million9.06% of portfolio
-
Alkeon Capital Management LLC New York, NY5.71MShares$38.9 Million0.09% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.27B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...